Former BoA Merrill Lynch banker joins Hua Medicine as CFO

China-headquartered Hua Medicine has named George Lin as its CFO.

Lin joined Hua from Bank of America Merrill Lynch where he was the head of Asia Pacific consumer, retail, and healthcare investment banking.

At Hua—which has plans to list either in Hong Kong or the US in the next 12 to 18 months, Lin is responsible for corporate finance and helping commercialize and licensing drugs.


Suggested Articles

Some of you might have already been aware of the news that Questex—with the aim to focus on event business—will shut down permanently all media brands in Asia…

Some advice for transitioning into an advisory role

Global risks are intensifying but the collective will to tackle them appears to be lacking. Check out this report for areas of concern